AndreaBozzo/ceres-open-data-index huggingface dataset:
SHIP Emergency Department Visits Related To Mental Health Conditions 2008-2017

Emergency Department Visits Related To Mental Health Conditions - This indicator shows the rate of emergency department visits related to mental health disorders* (per 100,000 population). Mental health problems can place a heavy burden on the healthcare system, particularly when persons in crisis utilize emergency departments instead of other sources of care when available. In Maryland, there were 207,650 mental health disorder-related emergency department visits in 2014.*Diagnoses include adjustment disorders, anxiety disorders, attention deficit disorders, disruptive behavior disorders, mood disorders, personality disorders, schizophrenia, and other psychotic disorders, suicide and intentional self-inflicted injury and miscellaneous mental disorders.
Patent AT-E401131-T1: [Translated] PROCESSING APPARATUS FOR MEDICINAL PRODUCTS AND METHOD

This disclosure relates to a centrifugal vortex system for preparing a liquid, such as fuel and includes a chamber housing defining a vortex chamber. An array of tangential apertures are formed in the chamber housing to permit fluid to be turbulently introduced into the vortex chamber to create a vortical flow of fluid through the vortex chamber. In one embodiment, a plurality of vortex chambers are arranged in series to allow the fluid to pass through several vortex chambers. In other embodiments, the chamber housing may be stepped, textured, or both to increase the turbulence of the flow through the chamber. In yet another embodiment, a pressure differential supply jacket is provided to normalize the amount of flow through the tangential apertures according to the location of the apertures. A centrifuge chamber is also disclosed which has a plurality of output conduits on a bottom surface and a tapered extension member downwardly extending from a top surface to enhance the centrifugal flow of the fluid. Additionally, a bypass conduit is provided to selectively permit the flow to bypass one or more chambers.
Business Rules PUF - PY2018

The Business Rules PUF (BR-PUF) is one of the files that make up the Marketplace PUF. The BR-PUF contains plan-level data on the application of rates, such as allowed relationships (e.g., spouse, dependents) and tobacco use. These data either originate from the Business Rules template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).
Compound 526793: 5-Hydroxy-nonadecanoic, delta-lactone

Chemical compound data from PubChem database. IUPAC Name: 6-tetradecyloxan-2-one. Molecular Formula: C19H36O2. Molecular Weight: 296.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528983: 1,2-Octacosanediol, di-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl(1-trimethylsilyloxyoctacosan-2-yloxy)silane. Molecular Formula: C34H74O2Si2. Molecular Weight: 571.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525728: (p-Methylbenzylidene)-nonyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-methylphenyl)-N-nonylmethanimine. Molecular Formula: C17H27N. Molecular Weight: 245.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526071: 1-Octadecanol, 16-methyl, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl(16-methyloctadecoxy)silane. Molecular Formula: C22H48OSi. Molecular Weight: 356.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Risk and Protective Factors Tables (Prevalence Estimates) - 3.1 to 3.25

These detailed tables present totals and prevalence estimates of risk and protective factors regarding substance use from the 2010 National Survey on Drug Use and Health (NSDUH). The factors include perceptions of 1) risk of substance use, 2) availability of substances, 3) parental disapproval of youth substance use, 4) peer substance use. They also include measures of delinquent behavior, religious involvement, exposure to prevention messages, and parental involvement. Results are provided by age group, gender, race/ethnicity, geographic area, and youth substance use behavior. Comparisons are made between 2010 and 2009.
Provisional COVID-19 Deaths by Week and Urbanicity

Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov.

Provisional COVID-19 deaths by urbanicity and week. Deaths are based on the county of occurrence in the United States. Urbanicity is defined as metropolitan and non-metropolitan, based on the 2013 National Center for Health Statistics (NCHS) Urban-Rural Classification Scheme for Counties. Counties are classified as “metropolitan” if they are large central metro, large fringe metro, medium metro or small metro; and “non-metropolitan” if micropolitan or non-core.
Compound 529014: 1,5-Dimethyl-2,4-diethylbenzene

Chemical compound data from PubChem database. IUPAC Name: 1,5-diethyl-2,4-dimethylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530123: Tryptophan, 5-hydroxy, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-(trimethylsilylamino)-3-(5-trimethylsilyloxy-1H-indol-3-yl)propanoate. Molecular Formula: C20H36N2O3Si3. Molecular Weight: 436.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Drug Use Data from Selected Hospitals

The National Hospital Care Survey (NHCS) collects data on patient care in hospital-based settings to describe patterns of health care delivery and utilization in the United States. Settings currently include inpatient and emergency departments (ED). From this collection, the NHCS contributes data that may inform emerging national health threats such as the current opioid public health emergency. The 2022 - 2024 NHCS are not yet fully operational so it is important to note that the data presented here are preliminary and not nationally representative.

The data are from 24 hospitals submitting inpatient and 23 hospitals submitting ED Uniform Bill (UB)-04 administrative claims from October 1, 2022–September 30, 2024. Even though the data are not nationally representative, they can provide insight into the use of opioids and other overdose drugs. The NHCS data is submitted from various types of hospitals (e.g., general/acute, children’s, etc.) and can show results from a variety of indicators related to drug use, such as overall drug use, comorbidities, and drug and polydrug overdose. NHCS data can also be used to report on patient conditions within the hospital over time.
Compound 530609: 3-Cyclopentylpropionic acid, 3-methylbut-2-enyl ester

Chemical compound data from PubChem database. IUPAC Name: 3-methylbut-2-enyl 3-cyclopentylpropanoate. Molecular Formula: C13H22O2. Molecular Weight: 210.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Matrix metalloproteinases in lung biology

Despite much information on their catalytic properties and gene regulation, we actually know very little of what matrix metalloproteinases (MMPs) do in tissues. The catalytic activity of these enzymes has been implicated to function in normal lung biology by participating in branching morphogenesis, homeostasis, and repair, among other events. Overexpression of MMPs, however, has also been blamed for much of the tissue destruction associated with lung inflammation and disease. Beyond their role in the turnover and degradation of extracellular matrix proteins, MMPs also process, activate, and deactivate a variety of soluble factors, and seldom is it readily apparent by presence alone if a specific proteinase in an inflammatory setting is contributing to a reparative or disease process. An important goal of MMP research will be to identify the actual substrates upon which specific enzymes act. This information, in turn, will lead to a clearer understanding of how these extracellular proteinases function in lung development, repair, and disease.
Nursing Home Cost Report (RHCF): 2023

The Nursing Home Cost Report (RHCF) is a uniform report completed by New York nursing homes to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations (Part 86-2.2), nursing homes are required to file financial and statistical data with DOH annually. The data filed is part of the cost report and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends.
Compound 525436: 3,5-Dithianonane

Chemical compound data from PubChem database. IUPAC Name: 1-(ethylsulfanylmethylsulfanyl)butane. Molecular Formula: C7H16S2. Molecular Weight: 164.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Discontinuous and non-discontinuous subgenomic RNA transcription in a nidovirus

Arteri-, corona-, toro- and roniviruses are evolutionarily related positive-strand RNA viruses, united in the order Nidovirales. The best studied nidoviruses, the corona- and arteriviruses, employ a unique transcription mechanism, which involves discontinuous RNA synthesis, a process resembling similarity-assisted copy-choice RNA recombination. During infection, multiple subgenomic (sg) mRNAs are transcribed from a mirror set of sg negative-strand RNA templates. The sg mRNAs all possess a short 5′ common leader sequence, derived from the 5′ end of the genomic RNA. The joining of the non-contiguous ‘leader’ and ‘body’ sequences presumably occurs during minus-strand synthesis. To study whether toroviruses use a similar transcription mechanism, we characterized the 5′ termini of the genome and the four sg mRNAs of Berne virus (BEV). We show that BEV mRNAs 3–5 lack a leader sequence. Surprisingly, however, RNA 2 does contain a leader, identical to the 5′-terminal 18 residues of the genome. Apparently, BEV combines discontinuous and non-discontinous RNA synthesis to produce its sg mRNAs. Our findings have important implications for the understanding of the mechanism and evolution of nidovirus transcription.
Compound 527707: 1,2,3,8-Tetrachlorodibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,3,8-tetrachlorodibenzofuran. Molecular Formula: C12H4Cl4O. Molecular Weight: 306.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401488-T1: [Translated] LADDER WITH PLATFORM AND FOLDING TUBULAR SAFETY DEVICES, ESPECIALLY FOR EXTENSION LADDER

The ladder has a balustrade tube (13) associated to a lower platform (15) and including lower and upper rails (17, 19) arranged at about 0.5 mm and 1 mm from the platform, respectively. The rails form a peripheral edge articulated to an upper plane (5). The edge is connected to side legs (27) slidably connected to a post (21) in the plane. The platform is foldably mounted in an out of service folded position in which the platform and tube are brought in the ladder plane to occupy only a less volume, from a service position where the platform and tube are deployed to protect a person.
4.13 Facilities detoxifying clients, by substance, facility operation, and primary focus of facility: 2011. Number and percent

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facilities detoxifying clients, by substance, facility operation, and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Health conditions among male workers in mining and other industries reliant on manual labor occupations: National Health Interview Survey, 2007–2018

The National Health Interview Survey (NHIS) is an annual cross-sectional survey that collects information on a broad range of health topics; it was developed by the National Center for Health Statistics (NCHS) and is currently administered by the U.S. Census Bureau. NHIS datasets for the years 2007–2018 were combined to ensure an adequate sample size to study currently working male miners. During 2007–2018, the NHIS included four core modules. The Family and Sample Adult core modules were used in the study. The Family core module collected health and sociodemographic information on each member of each family within the household. The Sample Adult core module collected health and industry and occupation information for the randomly chosen sample adult from each household interviewed.
Compound 529490: 2,4,6-Octatrienoic acid, 3,7-dimethyl-, methyl ester, (E,E)-

Chemical compound data from PubChem database. IUPAC Name: methyl 3,7-dimethylocta-2,4,6-trienoate. Molecular Formula: C11H16O2. Molecular Weight: 180.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400315-T1: [Translated] DEVICE FOR TREATING A WOUND

A control system (2) for use with a vacuum bandage (14) over a wound (300) includes a vacuum pump (110), a waste canister (26) operably coupled to the pump (110), and a fluid source (24). The canister (26) is coupled to the bandage (14) such that, when a vacuum is applied to the canister (26), the vacuum is applied to the bandage (14). The fluid source (22) is coupled to the bandage (14) to selectively introduce fluid into the wound (300) and the fluid source is coupled to a post (514) and held at an elevated position relative to the housing (4) of the control system.
Patent AT-E401133-T1: [Translated] FLUID DISPENSER PUMP

Chemical patent from PubChem database. Patent Number: AT-E401133-T1. Title: Combinatorial Chemistry Method. Filing Date: 1996-06-25. Inventors: Garcia, Maria, Miller, Thomas. Abstract: A combinatorial chemistry method for generating libraries of chemical compounds is disclosed, enabling rapid identification of lead compounds for drug... IPC Classifications: C12N, C12P, A61K. This patent covers 31 claims related to 5 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic

NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Inhaled nitric oxide reverses cell-free hemoglobin-induced pulmonary hypertension and decreased lung compliance. Preliminary results

Background:
          In order to test the hypothesis that inhaled nitric oxide (NO) reverses the pulmonary hypertension induced by αα-diaspirin crosslinked hemoglobin (ααHb), were studied anesthetized pigs that were administered with a total dose of 200 mg/kg of 10% ααHb. Inhaled NO (5 ppm) was administered for 10 min, and then discontinued for 10 min. This cycle was then repeated with 10 ppm inhaled NO.
        
        
          Results:
          ααHb caused pulmonary arterial pressure (PAP) to increase from 27 ± 1.7 to 40 ± 3.0 mmHg (P<0.05) and dynamic lung compliance to decrease from 29± 1.5 to 23± 1.6 ml/cmH2O (P < 0.05). After both doses of inhaled NO, but particularly 10 ppm, PAP was reduced (P < 0.05) and lung compliance increased (P < 0.05) from the ααHb levels. When inhaled NO was discontinued PAP again increased and lung compliance decreased to levels significantly different from baseline (P < 0.05).
        
        
          Conclusion:
          We conclude that cell-free hemoglobin-induced pulmonary hypertension and decreased lung compliance can be selectively counteracted by inhaled NO.
Compound 529497: Pentan-2-yl 3-methylbutanoate

Chemical compound data from PubChem database. IUPAC Name: pentan-2-yl 3-methylbutanoate. Molecular Formula: C10H20O2. Molecular Weight: 172.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525360: 2,3,6,7-Tetramethyl-4,5-dithiaoctane

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-(3-methylbutan-2-yldisulfanyl)butane. Molecular Formula: C10H22S2. Molecular Weight: 206.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401576-T1: [Translated] USE OF A NUCLEAR-RESTRICTED PROTEIN FOR THE DIAGNOSIS AND THERAPY OF ALZHEIMER'S DISEASE AND RELATED DEEP NEURODEGENERATION DISORDERS

The present invention discloses the differential expression of the gene coding for the nuclear restricted protein/brain, NRP/B, in specific brain regions of Alzheimer's disease patients. Based on this finding this invention provides a method for diagnosing or prognosticating a neurodegenerative disease, in particular Alzheimer's disease, in a subject, or for determining whether a subject is at increased risk of developing such a disease. Furthermore, this invention provides therapeutic and prophylactic methods for treating or preventing Alzheimer's disease and related neurodegenerative disorders using a gene coding for a nuclear restricted protein, in particular the nuclear restricted protein/brain, NRP/B. A method of screening for modulating agents of neurodegenerative diseases is also disclosed.
Compound 527571: 1-Bromo-4-methylcyclohex-1-ene

Chemical compound data from PubChem database. IUPAC Name: 1-bromo-4-methylcyclohexene. Molecular Formula: C7H11Br. Molecular Weight: 175.07. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529744: 1-Methyltetradecyl cyclopentanecarboxylate

Chemical compound data from PubChem database. IUPAC Name: 1-[(2-methylfuran-3-yl)disulfanyl]propan-2-one. Molecular Formula: C8H10O2S2. Molecular Weight: 202.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.